March 10: Coordinating Patent Prosecution in the U.S. and Europe

In today’s connected global economy, obtaining patent protection in multiple jurisdictions is the best way for companies to protect their IP on a global scale. But every jurisdiction has different patentability requirements and prosecution schemes, as well as quirks of local law that can significantly complicate the coordination of a global patent strategy.
Join Fish attorneys Peter Fasse and Moritz Ammelburg as they discuss best practices for obtaining patent protection in both the U.S. and Europe. Peter and Moritz will discuss the following topics, among others:
Inventorship, right of priority, and entitlement to file an application in the U.S. vs. Europe
Effective application drafting to meet both U.S. and European support standards
Submission of after-filing data to support enablement, non-obviousness, and inventive step in the U.S. and Europe
Title:
Coordinating Patent Prosecution in the U.S. and Europe
Webinar Date+Time:
Wednesday, March 10, 2021
1:30 - 2:30 PM ET
Register Now!
Speakers:
Peter Fasse and Moritz Ammelburg
By:
Fish & Richardson, P.C.
Credit:
Fish & Richardson is an accredited CLE provider by the California, New York, and Texas State Continuing Legal Education Boards. (California Provider Number 4933). Fish & Richardson will apply for 1.0 hour of CLE credit in some additional states. Credit will be awarded only to attorneys who report their required CLE states during their registration process and who log in and complete the webinar in its entirety. Note that Fish is unable to grant CLE credit to attendees who listen to the audio portion only.

Register Now!

January 27: Life Sciences Webinar: 2020 Year in Review

2020 has been referred to as an unprecedented year for the world in so many ways—the pandemic, the California and Washington fires, the racial justice protests and calls to action—but that didn’t stop the Federal Circuit from setting some highly impactful patent law precedent for the life sciences.
On January 27, Fish attorneys Chad Shear and Teresa Lavoie will discuss some of the most important of these developments. Where to begin?

• How about venue—and we mean that quite literally. We’ll discuss the impact of Valeant v. Mylan on Hatch-Waxman litigation venue. 
• Skinny labeling and inducement. As patent attorneys, we all know that timing and precise language matter—not only in patent claims, but also on drug labels. We’ll discuss the Federal Circuit’s analysis of the facts and holding in GSK v. Teva. 
• Many of us experienced our own version of Groundhog Day with respect to our day-to-day lives during the pandemic—each day wasn’t literally the same as the day before, but, wow, did they feel like they were. We’ll explore some patent law Groundhog Day analogies—the doctrine of equivalents in Lilly v. Apotex and 101 patent eligibility in Illumina v. Ariosa. 

Title:
Life Sciences Webinar Series - 2020 Year in Review
Webinar Date+Time:
Wednesday, January 27, 2021
1:30-2:30 PM ET
Register Now!
Speakers:

• Chad Shear 
• Teresa Lavoie

By:
Fish & Richardson, P.C.
Credit:
Fish & Richardson is an accredited CLE provider by the California, New York, and Texas State Continuing Legal Education Boards. (California Provider Number 4933). Fish & Richardson will apply for 1.0 hour of CLE credit in some additional states. Credit will be awarded only to attorneys who report their required CLE states during their registration process and who log in and complete the webinar in its entirety. Note that Fish is unable to grant CLE credit to attendees who listen to the audio portion only.
Register Now!

December 2: How To Prevent a Terrible, Horrible, No Good, Very Bad Day for Your Life Sciences Start-up: Lessons Learned From Company Formation, Drug Development, Partnering, and Due Diligence Nightmares

Some of the most appreciated aspects of life science start-ups are their agility, speed, focus, and creativity. But sometimes the application of those traits in company formation and evolution scenarios can result in scary and recurring nightmares for IP and corporate attorneys. Many of the mistakes life science start-ups commonly make during company formation can result in long-term negative consequences.
On Wednesday, December 2, join Fish Principals Chad Shear and Teresa Lavoie as they discuss some of the “horrible, no good, very bad day" scenarios they have witnessed in start-up formation and evolution, and as they provide practical advice to help minimize those horrible days. A few topics Chad and Teresa will discuss include:

• Early-stage deals and the importance of confidentiality
• Soliciting funding from third parties
• Dealing with egos
• Partnering with academics
• Determining what to disclose and to whom.

Title:

How To Prevent a Terrible, Horrible, No Good, Very Bad Day for Your Life Sciences Start-up: Lessons Learned From Company Formation, Drug Development, Partnering, and Due Diligence Nightmares 

Webinar Date+Time:

Wednesday, December 2, 2020

1:30-2:30 PM ET

Register Now! 

Speakers: 

By: 

Fish & Richardson, P.C.

Credit: Fish & Richardson is an accredited CLE provider by the California, New York, and Texas State Continuing Legal Education Boards. (California Provider Number 4933). Fish & Richardson will apply for 1.0 hour of CLE credit in some additional states. Credit will be awarded only to attorneys who report their required CLE states during their registration process and who log in and complete the webinar in its entirety. Note that Fish is unable to grant CLE credit to attendees who listen to the audio portion only. 

Register Now!

July 23: Biosimilars: A 2020 Mid-Year Review

Biologics are the fastest-growing class of therapeutic products in the United States. In 2019, the FDA approved 10 biosimilars—a new record. For pharmaceutical companies, this means that competition in the biosimilars space is heating up and creating a new sense of urgency to innovate.
On July 23, 2020, please join life sciences attorneys John Adkisson, Geoff Biegler, and Jenny Shmuel for a webinar, in which they will provide a mid-year update on the current U.S. biosimilars space. Topics to be discussed include recent developments regarding:

• The U.S. biosimilars market, including approvals and launches
• FDA announcements and guidance
• Select court cases and appellate guidance
• Trends in IPRs.

In addition, our hosts will discuss how the ongoing COVID-19 pandemic has impacted U.S. biosimilars and how it could continue to do so in the future.
Title:
Biosimilars: A 2020 Mid-Year Review
Webinar Date+Time:
Thursday, July 23, 2020
1:30 – 2:30 pm EDT
Register Now!
Speakers:

• John C. Adkisson
• Geoffrey D. Biegler
• Jenny Shmuel, Ph.D.

By:
Fish & Richardson, P.C.
Credit:
Fish & Richardson will apply for 1.0 hour of CLE credit.
Register Now!

July 21: Navigating to the Safe Harbor: What to Know in Advance

The last decade has been a time of tremendous growth in the biotechnology and biopharmaceutical industries, not only in the United States, but globally. At the same time, advances in drug development technologies and accelerated approval pathways in the USFDA and in other regulatory bodies have dramatically shortened the timeline and reduced the clinical risk profile in going from concept to commercial product. During this time of accelerated global research and development regarding diagnostics and treatments–especially for COVID-19 (SARS-CoV2)–it is more important than ever for pharma/biotech companies to determine in advance whether their programs are headed for rocky seas or the safe harbor.
Join Fish attorneys Teresa Lavoie and Brian Coggio on Tuesday, July 21, for a webinar covering these issues and more, including:

• The basics of § 271(e)(1) safe harbor
• “Basic research” and the Coronavirus
• Developments regarding
• Stockpiling
• Research tools
• Companion diagnostics
• Genetically-engineered animals.

Title:
Navigating to the Safe Harbor: What to Know in Advance
Webinar Date+Time:
Tuesday, July 21, 2020
1:30 pm EDT
Register Now!
Speakers:
Fish attorneys Teresa Lavoie and Brian Coggio
By:
Fish & Richardson, P.C.
Credit:
Fish & Richardson is an accredited CLE provider by the California, New York, and Texas State Continuing Legal Education Boards. (California Provider Number 4933). Fish & Richardson will apply for 1.0 hour of CLE credit in some additional states. Credit will be awarded only to attorneys who report their required CLE states during their registration process and who log in and complete the webinar in its entirety. Note that Fish is unable to grant CLE credit to attendees who listen to the audio portion only.
Register Now!

August 6: Post-Grant for Practitioners Webinar | Just the Facts - A Mid-Year Review

In this Fish webinar, Fish attorneys John Dragseth, Lauren Degnan, and Rob Courtney will provide a mid-year review of current developments in post-grant practice. Topics to be covered include:

• Thryv v. Click-to-Call and other issues concerning the appealability of institution decisions
• GE v. United Technologies and other issues concerning petitioner standing to appeal IPR decisions
• A practical update of Arthrex – Where are we? What’s next?
• An update on issues concerning IPR-related estoppels.

Title:
Post-Grant for Practitioners Webinar | Just the Facts - A Mid-Year Review
Webinar Date+Time:
Thursday, August 6, 2020
1:30 – 2:30 pm EDT
Register Now!
Speakers:

• John Dragseth
• Lauren Degnan
• Rob Courtney 

By:
Fish & Richardson, P.C.
Credit:
Fish & Richardson will apply for 1.0 hour of CLE credit.
Register Now!

August 13: The Impact of Patent Term Extension on Litigation Under the Hatch-Waxman Act: A Look at the Federal Circuit’s Recent Decision in Biogen v. Banner Life Scis.

Section 156 of the Patent Act provides for a patent term extension for FDA-regulated products to compensate for delays in obtaining approval. But what constitutes a “product” under this regulatory scheme? In a recent decision, the Federal Circuit relied on the definition of Section 156, holding that a ‘product’ means the ‘active ingredient… including any salt or ester of the active ingredient’ without expanding the definition and does not include any metabolite of the active ingredient of the product or its de-esterfied form.
On Thursday, August 13, Fish attorneys Robert Oakes and Kelly Allenspach Del Dotto will review the case and its implications for Hatch-Waxman litigation. Among other topics, our speakers will discuss:

• The purpose behind the patent term extension provision of 35 U.S.C. § 156
• Section 156’s restrictions on patent term extension and what the statute defines as a “product”
• The Biogen Int’l GmbH. v. Banner Life Scis. LLC decision, and the impact it could have on Hatch-Waxman litigation.

Title:
The Impact of Patent Term Extension on Litigation Under the Hatch-Waxman Act: A Look at the Federal Circuit’s Recent Decision in Biogen v. Banner Life Scis.
Webinar Date+Time:
Thursday, August 13th, 2020
1:30 pm EDT
Register Now!
Speakers:

• Robert Oakes 
• Kelly Allenspach Del Dotto. 

By:
Fish & Richardson, P.C.
Credit:
Fish & Richardson is an accredited CLE provider by the California, New York, and Texas State Continuing Legal Education Boards. (California Provider Number 4933). Fish & Richardson will apply for 1.0 hour of CLE credit in some additional states. Credit will be awarded only to attorneys who report their required CLE states during their registration process and who log in and complete the webinar in its entirety. Note that Fish is unable to grant CLE credit to attendees who listen to the audio portion only.

Register Now!

July 30: Structuring Biotech & Pharma Startup Portfolios for Global Impact, Value, and Partnering

With continued significant investment by venture, PE, and pharma communities in biotech clusters around the world, ensuring that your portfolio can provide maximum value on a global scale for ultimate partnering or acquisition is a crucial element of any startup’s strategic plan. Important considerations include:

• Balancing early filing/first to file realities with meeting enablement and support requirements in the US and around the world
• You can’t do it all alone: best practices for working with CROs, consultants, and universities
• Even though you have a million other things to focus on, don’t forget the details: inventorship, ownership, and chain of title.

On Tuesday, July 30, please join Fish attorneys Teresa Lavoie and Angela Follett as they discuss global filing and portfolio strategies for startups in the biotech and pharma sectors.
Title:
Structuring Biotech & Pharma Startup Portfolios for Global Impact, Value, and Partnering
Webinar Date+Time:
Thursday, July 30, 2020
1:30 – 2:30 pm EDT
Register Now!
Speakers:
Teresa A. Lavoie, Ph.D.
Angela D. Follett, Ph.D.
By:
Fish & Richardson, P.C.
Credit:
Fish & Richardson will apply for 1.0 hour of CLE credit.
Register Now!

May 6: How to Defeat an Alice Rejection

In 2014, the Supreme Court in Alice held that patent claims directed to abstract ideas are patent-ineligible unless they recite something "significantly more" than the abstract idea. What "significantly more" means has been a matter of confusion and debate ever since, particularly for patent examiners at the USPTO. For software patent applicants faced with § 101 rejections, the "significantly more" standard is a significant hurdle to overcome.

In this free patent webinar, Fish Principals Jonathan Lamberson and David Goren will discuss strategies for overcoming § 101 rejections, including:

• A discussion of recent developments in Alice jurisprudence at the PTAB and in district courts;
• Claim drafting techniques for avoiding rejections; and
• Ways to craft arguments under Alice Steps 1 and 2 to get you to allowance.

Title:
How to Defeat an Alice Rejection Webinar
Webinar Date+Time:
Wednesday, May 6, 2020
1:30-2:30 PM EDT
Register Now!
By:
Fish & Richardson, P.C.
Credit:
Fish & Richardson is an accredited CLE provider by the California, New York, and Texas State Continuing Legal Education Boards. (California Provider Number 4933). Fish & Richardson will apply for 1.0 hour of CLE credit in some additional states. Credit will be awarded only to attorneys who report their required CLE states during their registration process and who log in and complete the webinar in its entirety. Note that Fish is unable to grant CLE credit to attendees who listen to the audio portion only.
Register Now!